BullBD Old Apps Site
Home
Favorites
Recently viewed Details Chart Today news Share news Top gainer Top Looser Upcoming events
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0 1 2 3 4 5 6 7 8 9 All
Bank Cement Ceramics Sector Corporate Bond Engineering Financial Institutions Food & Allied Fuel & Power IT Sector Insurance Jute Life Insurance Miscellaneous Mutual Funds Paper & Printing Pharmaceuticals & Chemicals Services & Real Estate Tannery Industries Telecommunication Textile Travel & Leisure All
  • Details
  • Chart
  • News

BEACONPHAR

All Eps Dividend Board Agm Q1 Q2 Q3

BEACONPHAR 05-May-2021

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on May 18, 2021 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended on March 31, 2021.

BEACONPHAR 28-Mar-2021

(Continuation news of BEACONPHAR): But no written agreement/deal has made yet. On the other hand worldwide COVID-19 situation is going down very roughly. In this situation we are not confirm regarding this deal before signing the agreement. We also assure you, after completion of the signing ceremony with the government of Syria we will inform you and other regulatory authorities on time." (end)

BEACONPHAR 28-Mar-2021

(Continuation news of BEACONPHAR): If the Syrian government agreed we may export USD 5.00 million worth of pharmaceuticals to Syria by December, 2021 and have the potential to increase exports to USD 10.00 million within one year which may have a positive financial impact of the Company. (Cont. 2)

BEACONPHAR 28-Mar-2021

In response to a DSE query dated March 24, 2021 regarding clarification on recent news published in the newspaper, the Company has informed that "We like to inform that a technical team of the government of Syria inspected the plant of Beacon Pharmaceuticals Limited on March 08, 2021. They expressed their satisfaction verbally on the Company?s overall operations in drugs manufacturing. (Cont. 1)

BEACONPHAR 16-Mar-2021

In response to a DSE query dated March 15, 2021, the Company has informed that there is no undisclosed price sensitive information of the Company for recent unusual price hike and increase in volume of shares.

BEACONPHAR 31-Jan-2021

(Q2 Un-audited): EPS was Tk. 1.01 for October-December 2020 as against Tk. 0.12 for October-December 2019; EPS was Tk. 1.26 for July-December 2020 as against Tk. 0.30 for July-December 2019. NOCFPS was Tk. (0.48) for July-December 2020 as against Tk. (0.30) for July-December 2019. NAV per share was Tk. 20.71 as on December 31, 2020 and Tk. 12.79 as on December 31, 2019.

BEACONPHAR 24-Jan-2021

The Company has informed that it has disbursed the cash dividend warrants for the year ended on June 30, 2020 to the respective shareholders through courier service.

BEACONPHAR 24-Jan-2021

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 28, 2021 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended on December 31, 2020.

BEACONPHAR 26-Nov-2020

Credit Rating Agency of Bangladesh Limited (CRAB) has announced the Entity (surveillance) Rating of the Company as "A2" based on audited financial statements up to June 30, 2020; bank liability position as on June 30, 2020 and other relevant quantitative as well as qualitative information up to the date of rating declaration.

BEACONPHAR 22-Nov-2020

Trading of the shares of the Company will resume on 23.11.2020 after record date.

Previous Next page